The Global Sjogren's Syndrome market is expected to reach USD 2.1 billion with the increasing number of lupus and rheumatoid arthritis cases worldwide

Hyderabad, June 21, 2019 -- The "Sjogren's Syndrome Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.
Global Sjögren’s syndrome market will reach USD 2 billion by 2024, driven primarily by the launch of Bristol-Myers Squibb’s Orencia from 2021.
Click here to get your copy of free sample https://www.datamintelligence.com/research-report/sjogrens-syndrome-market

Sjogren's Syndrome Market Trends : Drivers and Restraints
⦁ Factors driving the market include the growing patient population of diseases that can cause SS such as lupus and rheumatoid arthritis.
⦁ Increasing awareness and hence the demand for advanced treatment.
⦁ However, the lack of a cure for Sjögren’s syndrome will impact market growth.
⦁ Many of the currently available treatments for SS either only relieve the symptoms or are considered ineffective in many patients.

Sjogren's Syndrome Market Segmentation:
By Type
⦁ Primary Sjogren's Syndrome
⦁ Secondary Sjogren's Syndrome
By Drug Class
⦁ Cholinergic Agonists
⦁ Off-Label Drugs
By Distribution Channel
⦁ Hospital Pharmacy
⦁ Retail Pharmacy
⦁ Online Pharmacies
By Region
⦁ Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
⦁ Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
⦁ North America (The USA, Canada, Mexico)
⦁ South America (Brazil, Argentina, Rest of South America)
⦁ Rest of the World

Key Points covered in the report
⦁ Sjogren's Syndrome Market – Methodology and Scope
⦁ Sjogren's Syndrome Market – Trends
⦁ Sjogren's Syndrome Market – Industry Analysis
⦁ Geographical Analysis
⦁ Competitive Landscape
⦁ Company Profiles

Sjogren's Syndrome Market Key Companies
Novartis AG, Allergan Inc., Otsuka Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd., Nicox S.A., Argentis Pharmaceuticals, LLC., Auven Therapeutics, Bridge Pharma Inc. and Cellzome GmbH.
For more information about this report visit https://www.datamintelligence.com/research-report/sjogrens-syndrome-market
DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

About DataM Intelligence :
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historic data but also allows a highly justifiable forecast model.
DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery and Automation among others.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence.

This release was published on openPR.